Related Experiment Video
Updated: Jul 15, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Natural history and familial characteristics of isolated left ventricular non-compaction
Ross T Murphy1, Rajesh Thaman, Juan Gimeno Blanes
1The Heart Hospital, University College London, 16-18 Westmoreland Street, London W1G 8PH, UK.
Insights
Left Ventricular Non-compaction (LVNC) is a rare heart condition. This study found LVNC has a better prognosis than previously thought and identified familial incidence, with relatives showing related cardiac abnormalities.
Area of Science:
- Cardiology
- Genetics
- Medical Diagnostics
Background:
- Left Ventricular Non-compaction (LVNC) is a rare congenital heart disorder characterized by excessive myocardial trabeculations.
- Previous literature indicated a poor prognosis for adult LVNC, but familial and asymptomatic cases suggest a potential for a prolonged pre-clinical phase.
Purpose of the Study:
- To investigate the prognosis of Left Ventricular Non-compaction (LVNC) in a cohort of adult patients.
- To determine the familial incidence and spectrum of cardiac abnormalities in relatives of LVNC patients.
Main Methods:
- A 10-year retrospective study of 45 LVNC patients diagnosed at a cardiomyopathy referral center.
- Systematic echocardiographic screening of asymptomatic relatives of affected individuals.
Main Results:
- The study cohort (mean age 37) frequently presented with dyspnea (62%), abnormal ECG (91%), and impaired systolic function (66%).
- Mean survival was high (97% at 46 months), with a low rate of thromboembolic events (4%).
- Familial screening revealed LVNC or related abnormalities in 25% of asymptomatic relatives.
Conclusions:
- LVNC is associated with a better prognosis than previously reported in the literature.
- Familial LVNC can present with a spectrum of cardiac findings, including features resembling dilated cardiomyopathy in relatives.
Aims:
Non-compaction of the left ventricle (LVNC) is a disorder of endomyocardial morphogenesis that results in multiple trabeculations in the left ventricular myocardium. The current literature suggests that LVNC in adults is rare and associated with a poor prognosis. Given that the disorder is present at birth and that several studies have reported asymptomatic familial disease in some patients, we hypothesized that there is a long pre-clinical phase of the disease. The aim of this study was to define the prognosis and familial incidence of LVNC.
Methods And Results:
This study cohort comprised 45 patients (mean age at diagnosis 37 years) consecutively identified at a referral centre for cardiomyopathy over a 10-year period. Twenty-eight patients (62%) had dyspnoea at presentation; 41 (91%) an abnormal ECG; and 30 (66%) left ventricular dilatation and impaired systolic function. Nine patients (20%) had non-sustained ventricular tachycardia on 24 h Holter monitoring. Mean survival from death or transplantation was 97% at 46 months. There were three thromboembolic events in two patients (4%). On systematic family screening, 8 of 32 (25%) asymptomatic relatives had a range of echocardiographic abnormalities, including LVNC, LVNC with impaired systolic function, and left ventricular enlargement without LVNC.
Conclusion:
This study demonstrates that LVNC is associated with a better prognosis than previously reported. In patients with familial disease, relatives may have features consistent with dilated cardiomyopathy rather than LVNC.
Related Concept Videos
Specialized Characteristics of Cardiac Muscles
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy

